See the Glossary for more terms.
Concepts represent early planning stages for program announcements, request for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to the Opportunities and Announcements portal.
NB: Council approval does not guarantee that a concept will become an initiative.
For the published program announcements reviewed in an institute, see the June 4, 2014, Guide announcements, Basic Research on HIV Persistence (R01) and Basic Research on HIV Persistence (R21).
Broad Agency Announcement
Contact: Eileen Webster-Cissel
Objective: There are no vaccine products proven to elicit defined anti-HIV immune effector functions in infected humans. This initiative will support product development to fill that gap and allow critical evaluation of therapeutic vaccine products or vectored anti-HIV antibodies.
Description: This initiative will support developing therapeutic vaccine products, manufacturing, IND-enabling work, immune-monitoring development work for a study, and early-phase 1 or 1 plus 2a clinical studies of the product.
Last Updated June 11, 2014
Last Reviewed February 06, 2014